Decreased NF-κB activation has been observed following treatment with calcium chelators and experimental data from ethanol and cerulein models of pancreatitis has determined that NF-κB activation is mediated by calcium/calcineurin and PKC pathways (Satoh et al., 2004; Muili et al., 2012). Here, NFKB1 is linked to pancreatitis.